Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

Brittany K. Smith; Andrew Janowski; Arim C. Fremont; Lucas J. Adams; Ya Nan Dai; Christopher Farnsworth; Ann Gronowski; Stephen Roper; David Wang; Daved Fremont

doi:10.1128/mSphere.00450-21

Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

Brittany K. Smith
, Andrew Janowski
, Arim C. Fremont
, Lucas J. Adams
, Ya Nan Dai
, Christopher Farnsworth
, Ann Gronowski
, Stephen Roper
, David Wang
, Daved Fremont

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity was assessed for 3,066 individuals visiting hospitals in St. Louis, Missouri, during July 2020, November 2020, or January 2021. Seropositivity in children increased from 5.22% in July to 21.16% in January. In the same time frame, seropositivity among adults increased from 4.52% to 19.03%, prior to initiation of mass vaccination.

Original language	English
Pages (from-to)	1-5
Number of pages	5
Journal	mSphere
Volume	6
Issue number	4
DOIs	https://doi.org/10.1128/mSphere.00450-21
State	Published - Aug 2021

Keywords

COVID-19
ELISA
SARS-CoV-2
serology
seroprevalence

Access to Document

10.1128/mSphere.00450-21

Cite this

@article{d7738ad0978348b28411de69678ad01a,

title = "Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021",

abstract = "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity was assessed for 3,066 individuals visiting hospitals in St. Louis, Missouri, during July 2020, November 2020, or January 2021. Seropositivity in children increased from 5.22\% in July to 21.16\% in January. In the same time frame, seropositivity among adults increased from 4.52\% to 19.03\%, prior to initiation of mass vaccination.",

keywords = "COVID-19, ELISA, SARS-CoV-2, serology, seroprevalence",

author = "Smith, \{Brittany K.\} and Andrew Janowski and Fremont, \{Arim C.\} and Adams, \{Lucas J.\} and Dai, \{Ya Nan\} and Christopher Farnsworth and Ann Gronowski and Stephen Roper and David Wang and Daved Fremont",

note = "Publisher Copyright: {\textcopyright} 2021. Smith et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license.",

year = "2021",

month = aug,

doi = "10.1128/mSphere.00450-21",

language = "English",

volume = "6",

pages = "1--5",

journal = "mSphere",

issn = "2379-5042",

number = "4",

}

TY - JOUR

T1 - Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

AU - Smith, Brittany K.

AU - Janowski, Andrew

AU - Fremont, Arim C.

AU - Adams, Lucas J.

AU - Dai, Ya Nan

AU - Farnsworth, Christopher

AU - Gronowski, Ann

AU - Roper, Stephen

AU - Wang, David

AU - Fremont, Daved

PY - 2021/8

Y1 - 2021/8

N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity was assessed for 3,066 individuals visiting hospitals in St. Louis, Missouri, during July 2020, November 2020, or January 2021. Seropositivity in children increased from 5.22% in July to 21.16% in January. In the same time frame, seropositivity among adults increased from 4.52% to 19.03%, prior to initiation of mass vaccination.

AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seropositivity was assessed for 3,066 individuals visiting hospitals in St. Louis, Missouri, during July 2020, November 2020, or January 2021. Seropositivity in children increased from 5.22% in July to 21.16% in January. In the same time frame, seropositivity among adults increased from 4.52% to 19.03%, prior to initiation of mass vaccination.

KW - COVID-19

KW - ELISA

KW - SARS-CoV-2

KW - serology

KW - seroprevalence

UR - https://www.scopus.com/pages/publications/85115040422

U2 - 10.1128/mSphere.00450-21

DO - 10.1128/mSphere.00450-21

M3 - Article

C2 - 34346705

AN - SCOPUS:85115040422

SN - 2379-5042

VL - 6

SP - 1

EP - 5

JO - mSphere

JF - mSphere

IS - 4

ER -

Progression of SARS-CoV-2 Seroprevalence in St. Louis, Missouri, through January 2021

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this